Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Thumbnail

Reliance on inpatient BP readings may cause overtreatment

About 14 percent of older adults hospitalized for common, non-cardiac conditions were discharged with more intensive blood pressure medication, according to an analysis published in The BMJ. The concerning part: More than half of those patients actually demonstrated good blood pressure (BP) control in an outpatient setting, suggesting overtreatment from hospital physicians.

Thumbnail

Long-term exposure to air pollution might elevate risk of T2D

Extensive exposure to air pollutants like nitrogen dioxide and fine particulate matter could feed the development of type 2 diabetes (T2D), Chinese researchers reported in a meta-analysis published this month in the European Journal of Endocrinology.

2nd carcinogen detected in common heart drug valsartan

The European Medicines Agency (EMA) and the FDA said late last week a second toxin that may cause cancer has been detected in valsartan—a common heart drug that has already been recalled in about two dozen countries due to the presence of N-nitrosodimethylamine (NDMA), a probable human carcinogen.

Thumbnail

AHA tightens criteria for diagnosis of resistant hypertension

The American Heart Association has tightened its guidelines for diagnosing resistant hypertension—a condition that affects up to 15 percent of patients treated for high blood pressure—according to a scientific statement published this month.

Thumbnail

Wearable ultrasound patch can monitor BP 4 cm below skin

Scientists have developed a wearable ultrasound device to measure central blood pressure (BP). It performed as well as a current noninvasive technique upon testing, according to a press release.

‘Reassuring’ news: Tainted valsartan didn’t increase short-term cancer risk

Carcinogen-containing valsartan products that were recalled in about two dozen countries over the past few months didn’t significantly raise cancer risk in the short term, according to a Danish registry study published online Sept. 12 in The BMJ.

Thumbnail

How diabetics can prepare for Hurricane Florence

As extreme weather hits the East Coast this weekend, residents are stocking up on nonperishables, buying batteries in bulk and boarding up windows. But storm preparation looks a little different for diabetics, who are forced to consider their medical needs weeks in advance, Everyday Health reports.

Thumbnail

Is ‘time at target' a useful concept for controlling blood pressure?

The concept of “time in range” has been used in warfarin monitoring and glycemic management for diabetic patients, but why hasn't it caught on as a useful metric in controlling hypertension?